Copernicus Capital Management as of June 30, 2021
Portfolio Holdings for Copernicus Capital Management
Copernicus Capital Management holds 11 positions in its portfolio as reported in the June 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Vertex Pharmaceuticals Incorporated (VRTX) | 28.6 | $1.8M | 9.0k | 201.67 | |
| Fate Therapeutics (FATE) | 13.7 | $868k | 10k | 86.80 | |
| Atara Biotherapeutics | 12.3 | $778k | 50k | 15.56 | |
| Zentalis Pharmaceuticals (ZNTL) | 8.4 | $532k | 10k | 53.20 | |
| Tcr2 Therapeutics Inc cs | 7.8 | $492k | 30k | 16.40 | |
| Horizon Therapeutics Pub L SHS | 7.4 | $468k | 5.0k | 93.60 | |
| Accolade (ACCD) | 6.0 | $380k | 7.0k | 54.29 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 5.6 | $355k | 2.0k | 177.50 | |
| Gritstone Oncology Ord (GRTS) | 5.0 | $320k | 35k | 9.14 | |
| The Beauty Health Company Com Cl A (SKIN) | 2.6 | $168k | 10k | 16.80 | |
| Arcus Biosciences Incorporated (RCUS) | 2.6 | $165k | 20k | 8.25 |
